FGF23 and hydrops fetalis: Our observed association between circulating FGF23 and risk of death or HF hospitalization in HFpEF confirms similar findings from a retrospective analysis of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) Trial23 as well as from a recently published prospective, observational study.24